Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for Arrhythmic Risk in Diabetes and CHD
NCT04117763Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Oct 2019
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in cardiac arrhythmia, sponsored by Universidade de São Paulo. Started Oct 2019; status: completed.
02
Drugs
empagliflozin
03
Conditions
cardiac arrhythmia
Beyond the preview
Go deeper on NCT04117763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04117763.